Biontech vs Natera
Biontech is the larger business, with $3.24bn of revenue in fiscal 2025 against $2.31bn for Natera (1.4 times as much). Natera grew faster (35.9% against 9.0%). Natera kept more of each dollar of sales as profit: a net margin of -9.0% against -39.6%. Biontech carries less debt relative to equity (0.0% against 4.7%).
| Latest fiscal year | BiontechBNTX, 2025 | NateraNTRA, 2025 |
|---|---|---|
| Revenue | $3.24bn | $2.31bn |
| Revenue growth | 9.0% | 35.9% |
| Net income | −$1.28bn | −$208m |
| Operating margin | -49.0% | -13.4% |
| Net margin | -39.6% | -9.0% |
| Return on equity | -6.0% | -14.3% |
| Free cash flow | $318m | $109m |
| Cash | $9.01bn | $1.08bn |
| Total debt | $0 | $80.3m |
| Debt to equity | 0.0% | 4.7% |
| Dividend per share | — | — |
| Dividend yield | 0.0% | — |
| Share buybacks | — | — |
| Employees | — | — |
| Market value | $21.84bn | $56.04bn |
| Price vs our value range | Below our value range | — |
| Moat score | — | 17 (Weak) |
| Insider trades, 12 months | 0 buys, 27 sales | 0 buys, 511 sales |